Log In
BCIQ
Print this Print this
 

Panexia

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionDetects inherited mutations in the partner and localizer of BRCA2 (PALB2) and breast cancer 2 early onset (BRCA2) genes
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect hereditary pancreatic cancer.
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today